 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Search Grants |
|
|
|
|
|
|
|
| Program: | CIHR Fellowships | | Sponsor(s): | Canadian Institutes of Health Research | | Details: | Fellowships provide support for highly qualified candidates at the post-PhD or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad. Applications are invited in all areas of health research. The level and duration of support will depend on the degree(s), level of training, and licensure (where applicable) held by the applicant. See also information about the CIHR Michael Smith Fellowship Award for Research in Schizophrenia. | | Deadline(s): | October 1, 2008; February 2, 2009 | | | | | | | Program: | Emerging Team Grant: Co-morbidity of brain disorders and other health problems | | Sponsor(s): | Canadian Institutes of Health Research | | Details: | The purpose of this funding opportunity is to further strengthen research on co-morbid (co-occurring or concurrent) disorders associated with mental illness, addiction, brain and nerve disorders, and sensory disorders by fostering multidisciplinary collaborations among researchers, organizations in other sectors (e.g. not-for-profit health organizations, government, healthcare/public health), and consumers. To achieve this objective, and to capture the interest and expertise in their respective research communities, the Institute of Neurosciences, Mental Health and Addiction (INMHA), in partnership with the Institute of Aging, the Institute of Immunity and Infection, the Public Health Agency of Canada, the Rx&D Health Research Foundation, the Provincial Centre of Excellence for Child and Youth Mental Health at CHEO, the Alzheimer Society Canada, the Alberta Health Services/Alberta Mental Health Board, and the Canadian Centre on Substance Abuse are pleased to announce this joint support for multidisciplinary emerging research teams. | | Deadline(s): | LOI Deadline: October 15, 2008; Application Deadline: May 1, 2009. | | | | | | | Program: | Functioning of People with Mental Disorders (R01) | | Sponsor(s): | National Institutes of Health (NIH)
National Institute of Mental Health (NIMH) | | Details: | Although considerable advances have been made in improving the symptoms associated with mental disorders, symptom improvement is often only modestly associated with improvements in daily functioning (i.e., the performance of social, occupational, and instrumental tasks of daily living), and most current treatments have limited impact on the functioning and participation of those with mental disorders. The purpose of this Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), is the application of biobehavioral science methods and approaches to: a) develop and refine definitions and measures of function, disability, and daily participation relevant to those with mental disorders; b) understand the ecological mechanisms, independent of symptom severity, that contribute to functioning and disability in this population; and c) develop and test novel interventions that specifically and directly target functional capacity and performance deficits of this population. | | | | | | | Program: | National Cooperative Drug Discovery and Development Groups (NCDDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01/U19) | | Sponsor(s): | National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA) | | Details: | The purpose of the National Cooperative Drug Discovery Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to accelerate innovative drug discovery, the development of pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction, and the development and validation of models for evaluating novel therapeutics for mental disorders. Partnerships between academia and industry are strongly encouraged. In addition, this FOA runs in parallel with FOAs of similar scientific intent for small businesses, PA-08-142 and PA-06-028 using the Small Business Innovation Research (SBIR [R43/R44]) and the Small Business Technology Transfer (STTR [R41/R42]) grant mechanisms. | | Deadline(s): | Letters of Intent Receipt Dates: September 3, 2008; January 24, 2009; August 17, 2009; Jan 24, 2010; Aug 17, 2010; Jan 24, 2011
Application Receipt Dates: October 3, 2008; February 24, 2009; September 17, 2009; Feb 24, 2010; Sep 17, 2010; Feb 24, 2011 | | | | | | | Program: | Developmental Pharmacology (R03) | | Sponsor(s): | Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Environmental Health Sciences (NIEHS) | | Details: | Funding under this request is intended to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence.
This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-08-216 that solicits applications under the R21 grant mechanism. See also PAR-07-416. | | Deadline(s): | Letters of Intent Receipt Dates: August 22, 2008, December 21, 2008, April 21, 2009, August 21, 2009, December 21, 2009, April 23, 2010
Application Due Dates: September 22, 2008, January 21, 2009, May 21, 2009, September 21, 2009, January 21, 2010, May 21, 2010 | | | | | | | Program: | Deep Sequencing and Haplotype Profiling of Mental Disorders (R01) | | Sponsor(s): | National Institutes of Health (NIH)
National Institute of Mental Health (NIMH) | | Details: | A special emphasis of this Funding Opportunity Announcement (FOA) is to support applications that implement large-scale studies and innovative analytical designs that will disaggregate a given mental disorder into components of finite risks. These developments may be evolutionary or may be fundamentally new and may lead to paradigm shifts in the field. Applications submitted in response to this FOA may propose new technologies for cost effective whole genome analysis and in-depth sequencing and analysis of candidate genes and genomic regions in pedigrees or in a sample of unrelated cases with mental disorders. Applications for large-scale haplotype analysis and the development of new analytical methods also are encouraged. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PAR-08-199, which solicits applications under the Collaborative R01 mechanism. | | | | | | | Program: | Technological Innovations for Interdisciplinary Research Incorporating the Behavioral and Social Sciences (SBIR [R43/R44]) | | Sponsor(s): | National Institutes of Health (NIH) | | Details: | Small Business Innovation Research (SBIR) grant applications are being solicited from small business concerns (SBCs) for development of new, innovative technologies for research integrating human social and/or behavioral science with other disciplines. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PAR-08-201, which solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Applications must involve collaborative teams in the development of the proposed technologies. These teams will be composed of at least one or more social and/or behavioral scientists engaged with other specialists in product development. | | Deadline(s): | September 17, 2008; January 15, 2009; May 1, 2009 | | | | | | | Program: | Silvio O. Conte Centers for Basic and Translational Mental Health Research (P50) | | Sponsor(s): | National Institutes of Health (NIH)
National Institute of Mental Health (NIMH) | | Details: | The National Institute of Mental Health (NIMH) invites applications for Conte Centers for Basic and Translational Mental Health Research. The purpose of these Centers is to support interdisciplinary teams of researchers engaging in integrative, novel, and creative experimental approaches to address high-risk, high-impact questions that will significantly advance the state of the science in brain and behavioral research relevant to mental health.The Conte Centers program is intended to support research demonstrating an extraordinary level of synergy, integration, and potential for advancement of the state of the field, and is intended only for projects that could not be achieved by using other, more standard grant mechanisms. Support is provided both for individual research projects and for core support that is critical to the integration across Center components. | | Deadline(s): | Letters of Intent Receipt Date(s): August 25, 2008, August 25, 2009, August 25, 2010
Application Receipt Date(s): September 23, 2008, September 23, 2009, September 23, 2010 | | | | | | | Program: | Probes and Instrumentation for Monitoring and Manipulating Nervous System Plasticity (SBIR [R43/R44]) | | Sponsor(s): | National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Nursing Research
National Institute on Aging
National Center for Complementary and Alternative Medicine | | Details: | This FOA solicits applications for projects to develop probes, instrumentation, and other tools for understanding, monitoring, and manipulating nervous system plasticity. Applications are not restricted to a particular type of technology, but resulting technologies should have the potential to advance significantly the current state of the art in neuroplasticity research. Projects responsive to this FOA include those that would improve currently existing tools and approaches in major ways, as well as those that would develop novel tools and approaches to better understand neuroplasticity.
| | Deadline(s): | Opening Date: July 5, 2008 (Earliest date an application may be submitted to Grants.gov)
April 5th, August 5th, and December 5th | | | | | | | Program: | Enhancing Zebrafish Research with Research Tools and Techniques (R01) | | Sponsor(s): | National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Human Genome Research Institute (NHGRI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of General Medical Sciences | | Details: | This FOA encourages investigator-initiated applications to develop new, high-priority research tools or techniques of high priority to the zebrafish community that will help exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research. Applications proposing tools or techniques that will enhance the ability to detect or characterize genes, proteins, molecules, and pathways of interest in development and aging, organ formation, neural processes, behavior, sensory processing, physiological processes, and disease processes are welcome. | | Deadline(s): | Opening Date: August 17, 2008 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): August 17, 2008, August 17, 2009, August 17, 2010
Application Due Date(s): September 17, 2008, September 17, 2009, September 17, 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
